Introduction
Thrombotic thrombocytopenic purpura (TTP) is a serious multisystem disease characterized pathologically by widespread intraluminal and subendothelial hyaline thrombi which involve the capillary and precapillary arterioles.' Clinically, 74% of patients manifest, at any given time during the illness, the triad of thrombocytopenia, microangiopathic haemolytic anaemia and neurological symptoms. Only 40% of patients present with the classic pentad of renal impairment, high temperature and the triad.2 Pregnancy is a wellrecognized condition associated with TTP. 3 Familial occurrence of TTP is rare, but well documented. 4 There is one previous report of two sisters who developed TTP during pregnancy.5 We report two further similar cases.
Case reports
The patients are members of a family of eight siblings, one male and seven females, the offsprings of non-related Palestinian parents. The first patient, at age 29 years, was in the 38th week of her first pregnancy when she had induction oflabour at another hospital in May 1983. The patient was febrile, jaundiced and thrombocytopenic with platelet count 9.0 x 109/1. She also had Coombs negative haemolytic anaemia. ANA test was negative. She delivered a healthy male baby. Haemolytic anaemia and thrombocytopenia persisted after delivery and failed to respond to steroid therapy. In July 1983 the patient was transferred to a hospital in London. The initial blood count there showed a white blood cell count of 10.4 x 109/1, platelets 13.0 x 109/l and haemoglobin 9.3 g/dl.
Peripheral blood smear showed spherocytes, fragmented and nucleated red blood cells. Bone marrow examination showed increased megakaryocytes. TTP was diagnosed and the patient was started on aspirin, dipyridamole and daily plasma exchange. Her blood count became normal 5 days later, but she relapsed shortly after plasma exchange was discontinued. Subsequently she received plasma infusion and achieved a second remission. The patient was maintained on aspirin and dipyridamole. She has been followed at The second patient is a previously healthy female, sister of the first patient. She was in the 23rd week of her first pregnancy when she was admitted to Hamad General Hospital with a 2 day history of epistaxis and spontaneous skin bruises. Physical examination revealed generalized purpuric rash and several skin bruises. She was normotensive. Laboratory investigations showed a white blood cell count of 16.8 x 109/1, haemoglobin 8.7 g/dl, platelets 9.0 x 109/1, reticulocytes 5.0%. A peripheral blood smear showed thrombocytopenia, neutrophilic leucocytosis, a fair number of fragmented red blood cells, and occasional nucleated red blood cells. Bone marrow examination showed no abnormalities. Lactic dehydrogenase was 1655 U/1. Blood urea nitrogen, serum creatinine, total bilirubin, liver enzymes and antithrombin III levels were within normal limits. Direct Coombs test was negative. The prothrombin time and the partial thromboplastin time were normal. Urine analysis showed more than 300 red blood cells/high power field. TTP was diagnosed. The patient was started on aspirin, dipyridamole and received plasma exchange for 10 days. Serial blood counts showed gradual improvement, and, on the sixth hospital day, the white blood cell count was 14.9 x 109/1, haemoglobin was 11 g/dl and platelets were 267 x 109/1. The patient was in the 25th week of gestation when she was discharged on aspirin, dipyridamole and periodic prophylactic fresh frozen plasma infusions at gradually increased intervals. Vaginal delivery was induced in the 34th week of gestation due to significant intrauterine fetal growth retardation. The 1800 g baby died 3 days later of sepsis. Pathological examination of the placenta showed multiple vascular infarcts. Prophylactic fresh frozen plasma infusion was discontinued 4 months afer delivery. Follow-up after the initial remission of TTP showed no evidence of relapse and currently she is fully asymptomatic and maintains normal blood count. Figure 1 shows the HLA types of our patients and their immediate family members. There seems to be no association between the HLA pattern and the development ofTTP in our patients. Four other sisters of the patients had normal pregnancies without haematological complications.
Discussion
The familial occurrence of TTP is rare. Five families affected with TTP in addition to three families affected with haemolytic uraemic syndrome, a closely related discorder, have been reported in the English literature.6'7 An autosomal recessive pattern of inheritance has been suggested since in all reported families only siblings were involved, except for one family in which mother and daughter were affected.6 Specific genetic markers have not been identified. TTP and haemolytic uraemic syndrome developed in two HLA identical siblings 6+ years apart8 but HLA studies were unremarkable in the present cases.
Pregnancy is a well-recognized condition predisposing to TTP,3 but there is only one report in the literature of two sisters who developed TTP during pregnancy. 5 The nature of the association between pregnancy and TTP is unclear. In Weiner's review the mean maternal age was 23.3 ± 6.8 years and the mean gestational age at the onset of symptoms was 23.5 ± 10.4 weeks.3 The mortality rate was 68% for those who did not receive plasma therapy whereas no deaths occurred among those who received plasma therapy. Eighty per cent of infants died as a direct or indirect result of the maternal disease. The cause of infant death appears to be intrauterine growth retardation due to placental infarction. 9 The prognosis of patients with TTP has improved considerably during the past two decades. TTP and severe pre-eclampsia shares many clinical and laboratory manifestations. It is important to differentiate between these two entities since termination of pregnancy which is therapeutic in pre-eclampsia was not shown to be helpful in TTP complicating pregnancy.3 Determination of antithrombin III level, which was shown to be low in pre-eclampsia and normal in TTP, is helpful in the differentiation between the two conditions.3
Larger than usual von Willebrand factor multimers were found in the plasma of patients with chronic relapsing TTP.'3 Recently Thorp et al. found a normal von Willebrand factor (vWF) multimeric pattern in six women with severe preeclampsia while larger then usual multimers of von Willebrand factor were present in plasma of a pregnant patient with chronic relapsing TTP.'4 They suggested that determination of the vWF multimeric pattern is useful in the differentiation between TTP and severe pre-eclampsia.
Despite the dramatic improvement in the prognosis ofTTP as a result ofmodern therapy, patients who recover from the initial episode of TTP are at considerable risk of relapse in the future.'5 Precipitating factors include infection, surgery and pregnancy. Based on this, women with a previous history of TTP, who wish to become pregnant, should have close follow-up during pregnancy with frequent monitoring of platelet count, haemoglobin, lactic dehydrogenase and blood film. Plasma therapy should be initiated at the earliest evidence of relapse of TTP. Consideration, as well, should be given to prophylactic plasma infusion for pregnant women with a history of relapsing TTP.
